千红制药(002550) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was ¥391,207,729.22, representing a 168.23% increase compared to ¥145,850,292.12 in the same period last year[8] - Net profit attributable to shareholders was ¥54,359,079.83, a significant turnaround from a loss of ¥25,354,444.81 in the previous year, marking a 314.40% increase[8] - The net profit after deducting non-recurring gains and losses was ¥49,040,766.23, compared to a loss of ¥31,312,327.41 last year, reflecting a 256.62% improvement[8] - Basic earnings per share increased to ¥0.04 from a loss of ¥0.02, showing a growth of 306.63%[8] - The weighted average return on equity rose to 2.58%, up from -1.09% in the previous year, an increase of 3.67 percentage points[8] - Total operating revenue for the first quarter reached ¥391,207,729.22, a significant increase from ¥145,850,292.12 in the previous period, representing a growth of approximately 168.8%[57] - Net profit for the current period was ¥61,407,210.72, a turnaround from a net loss of ¥15,397,627.08 in the previous period[71] - The total profit for the current period was ¥75,531,154.31, compared to a loss of ¥10,616,895.40 in the previous period[71] - The total comprehensive income attributable to the parent company's owners was ¥54,386,651.09, compared to a loss of ¥26,298,493.85 in the previous period[66] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,365,832,156.57, a decrease of 3.51% from ¥2,451,779,413.58 at the end of the previous year[8] - The company's total assets amounted to ¥2,466,645,007.03, a decrease from ¥2,541,128,465.18 at the end of the previous year[56] - The total liabilities decreased to ¥220,305,377.30 from ¥356,229,796.17, indicating a reduction of about 38.2%[56] - The total equity attributable to shareholders increased to ¥2,246,339,629.73 from ¥2,184,898,669.01, reflecting a growth of approximately 2.8%[56] - The total liabilities and equity amounted to ¥2,466,645,007.03, down from ¥2,541,128,465.18, indicating a decrease of about 2.9%[56] Cash Flow - The company reported a net cash flow from operating activities of -¥95,833,609.11, a decline of 702.71% compared to -¥11,938,804.90 in the same period last year[8] - Net cash flow from operating activities decreased by 83.89 million yuan year-on-year, mainly due to increased raw material purchases to meet sales growth[20] - Cash inflow from operating activities amounted to CNY 474,633,963.69, up from CNY 350,214,020.55 in the previous period, representing a growth of approximately 35.5%[74] - Cash outflow from operating activities totaled CNY 570,467,572.80, compared to CNY 362,152,825.45 in the previous period, indicating an increase of about 57.5%[77] - The net cash flow from investment activities was CNY 35,998,024.10, significantly lower than CNY 302,811,311.85 in the previous period[79] - Cash inflow from financing activities was CNY 2,414,714.05, a decrease from CNY 159,149,997.20 in the previous period[80] - The net cash flow from financing activities was positive CNY 1,851,196.15, compared to negative CNY 49,673,877.06 in the previous period[80] Expenses - Operating costs rose by 194.66% year-on-year, attributed to the corresponding increase in sales[20] - Tax expenses decreased by 36.48% year-on-year, mainly due to increased input tax from raw material purchases[20] - Sales expenses grew by 42.72% compared to the previous year, driven by sales growth[20] - Financial expenses decreased by 8.55 million yuan, primarily due to reduced exchange gains and losses during the reporting period[20] - Investment income decreased by 7.76 million yuan compared to the previous year, primarily due to reduced financial management income[20] - Research and development expenses were ¥11,063,032.30, up from ¥8,595,942.45, reflecting an increase of approximately 28.6%[67] - Tax expenses for the current period were ¥14,123,943.59, compared to ¥4,780,731.68 in the previous period, indicating an increase of approximately 195.5%[71] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 50,178, with the largest shareholder holding 19.96% of the shares[12] - The company reported a basic earnings per share of CNY 0.12 for the first quarter[72] Other Information - The company received government subsidies amounting to ¥5,909,616.31 during the reporting period[8] - The company maintained a stable long-term equity investment of ¥113,071,276.61, unchanged from the previous period[53] - The first quarter report for 2021 was not audited[87] - There were no adjustments needed for the beginning balance sheet items[87] - The company is not applying the new leasing standards retrospectively for prior comparative data[87]